Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis

Clinical and Experimental Allergy

Volumn 43, Issue 4, 2013, Pages 425-433

  Jung, J ^a,c   Kim, S H ^b   Lee, H S ^c   Choi, G S ^b   Jung, Y S ^a   Ryu, D H ^d   Park, H S ^b   Hwang, G S ^a,e  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Chungnam National University   (South Korea)

Author keywords

Asthma; Diagnosis; Metabolite profiling; Nuclear magnetic resonance

Indexed keywords

ACETIC ACID; ARGININE; BIOLOGICAL MARKER; CHOLINE; FORMIC ACID; GLUCOSE; GLUTAMINE; HISTIDINE; METHANOL; METHIONINE; PHOSPHORYLCHOLINE;

ACCURACY; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOXIA; IMMUNITY; LIPID METABOLISM; MALE; METABOLOMICS; METHYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASTHMA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NEUTROPHILS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SPUTUM; YOUNG ADULT;

EID: 84875512899     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12089     Document Type: Article

References (43)

1. Lazarus SC. Clinical practice. Emergency treatment of asthma. N Engl J Med 2010; 363:755-64.
2. Payne DN, Wilson NM, James A, Hablas H, Agrafioti C, Bush A. Evidence for different subgroups of difficult asthma in children. Thorax 2001; 56:345-50.
3. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164:2107-13.
4. Raamsdonk LM, Teusink B, Broadhurst D et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 2001; 19:45-50.
5. Jung JY, Lee HS, Kang DG et al. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 2011; 42:1282-8.
6. Carraro S, Rezzi S, Reniero F et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007; 175:986-90.
7. de Laurentiis G, Paris D, Melck D et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J 2008; 32:1175-83.
8. Saude EJ, Obiefuna IP, Somorjai RL et al. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. Am J Respir Crit Care Med 2009; 179:25-34.
9. Saude EJ, Skappak CD, Regush S et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 2011; 127:757-64.
10. Izquierdo-García JL, Peces-Barba G, Heili S, Diaz R, Want E, Ruiz-Cabello J. Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Eur Respir J 2011; 37:468-70.
11. Gomes-Alves P, Imrie M, Gray RD et al. SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. Clin Biochem 2010; 43:168-77.
12. Kaddurah-Daouk R, Krishnan KR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2009; 34:173-86.
13. Shin JH, Yang JY, Jeon BY et al. H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res 2011; 10:2238-47.
14. Malz F, Jancke H. Validation of quantitative NMR. J Pharm Biomed Anal 2005; 38:813-23.
15. Skov T, van den Berg F, Tomasi G, Bro R. Automated alignment of chromatographic data. J Chemom 2006; 20:484-97.
16. Keun HC, Ebbels TMD, Antti H et al. Improved analysis of multivariate data by variable stability scaling:application to NMR-based metabolic profiling. Analy Chim Acta 2003; 490:265-76.
17. Grove H, Jørgensen BM, Jessen F et al. Combination of statistical approaches for analysis of 2-DE data gives complementary results. J Proteome Res 2008; 7:5119-24.
18. Metz CE. Basic principle of ROC analysis. Semin Nucl Med 1978; 8:283-98.
19. Myers TR. Guidelines for asthma management: a review and comparison of 5 current guidelines. Respir Care 2008; 53:751-67; discussion 767-9.
20. National Institutes of Health. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, Maryland: National Institutes of Health, National Asthma Education and Prevention Program; NIH Publication No. 08-4051, 2007.
21. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr 2002; 13:2333S-5S.
22. Clarke S. Protein methylation. Curr Opin Cell Biol 1993; 5:977-83.
23. Selhub J, Seyoum E, Pomfret EA, Zeisel SH. Effects of choline deficiency and methotrexate treatment upon liver folate content and distribution. Cancer Res 1991; 51:16-21.
24. Lara A, Khatri SB, Wang Z et al. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008; 178:673-81.
25. Boisvert FM, Richard S. Arginine methylation regulates the cytokine response. Mol Cell 2004; 15:492-4.
26. Shin HJ, Park HY, Jeong SJ et al. STAT4 expression in human T cells is regulated by DNA methylation but not by promoter polymorphism. J Immunol 2005; 175:7143-50.
27. Schwartz DA. Epigenetics and environmental lung disease. Proc Am Thorac Soc 2010; 7:123-5.
28. Hollingsworth JW, Maruoka S, Boon K et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008; 118:3462-9.
29. Digel W, Lübbert M. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results. Crit Rev Oncol Hematol 2005; 55:1-11.
30. Choi JH, Oh SW, Kang MS, Kwon HJ, Oh GT, Kim DY. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 2005; 35:89-96.
31. Baritussio A. Lung surfactant, asthma, and allergens: a story in evolution. Am J Respir Crit Care Med 2004; 169:550-1.
32. Waddell JA, Emerson PA, Gunstone RF. Hypoxia in bronchial asthma. Br Med J 1967; 2:402-4.
33. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990; 86:599-605.
34. Fogarty A, Britton J. The role of diet in the aetiology of asthma. Clin Exp Allergy 2000; 30:615-27.
35. Gonen B, O'Donnell P, Post TJ, Quinn TJ, Schulman ES. Very low density lipoproteins (VLDL) trigger the release of histamine from human basophils. Biochim Biophys Acta 1987; 917:418-24.
36. De Lorenzo A, Maiolo C, Mohamed EI, Andreoli A, Petrone-De Luca P, Rossi P. Body composition analysis and changes in airways function in obese adults after hypocaloric diet. Chest 2001; 119:1409-15.
37. Cáp P, Chládek J, Pehal F et al. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax 2004; 59:465-70.
38. Dallinga JW, Robroeks CM, van Berkel JJ et al. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy 2010; 40:68-76.
39. Ibrahim B, Basanta M, Cadden P et al. Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax 2011; 66:804-9.
40. Kagoshima M, Wilcke T, Ito K et al. Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. Eur J Pharmacol 2001; 429:327-34.
41. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003; 139:359-70.
42. Turpeinen M, Sorva R, Juntunen-Backman K. Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 1991; 88:384-9.
43. Yagupsky P, Shahak E, Tal A, Bearman JE, Zuili I, Shany S. Lipoprotein profile of children with asthma receiving long-term theophylline therapy: a preliminary study. J Pediatr 1992; 120:802-5.